why choose us

First received: October 30, 2023

Clinical Trial: A Real-world, Multi-center, Prospective, Observational Study for PNH in China

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Paroxysmal Nocturnal Hemoglobinuria

Study Type: OBSERVATIONAL


Official Title: A Real-world, Multi-center, Prospective, Observational Study for Paroxysmal Nocturnal Haemoglobinuria (PNH) in China

Brief Summary: As a rare disease listed in the First Catalogue of Rare Diseases in China (National Health Commission of the People's Republic of China, 2019), PNH is poorly studied in China subse-quently leading to the inadequate elucidation of disease characteristics and clinical outcomes.Eculizumab was recently approved by NMPA.The availability of Eculizumab in China pro-vides people living with PNH with a new treatment option that can reduce disease symptoms and prevent the dysregulated complement system from causing…

Read more